South Korea Host Cell Protein Testing Market Size, Share, and COVID-19 Impact Analysis, By Type (PCR-Based Assays, ELISA-Based Assays, Mass Spectrometry-Based Assays, and Others) and By End User (Contract Research Organizations, Biopharmaceutical Companies, and Others), and South Korea Host Cell Protein Testing Market Insights, Industry Trend, Forecasts to 2035

South Korea Host Cell Protein Testing Market Insights Forecasts to 2035

• The South Korea Host Cell Protein Testing Market Size Was Estimated at USD 33.21 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.57% from 2025 to 2035
• The South Korea Host Cell Protein Testing Market Size is Expected to Reach USD 66.89 Million by 2035

According to a research report published by Spherical Insights & Consulting, the South Korea Host Cell Protein Testing Market Size is anticipated to reach USD 66.89 Million by 2035, Growing at a CAGR of 6.57% from 2025 to 2035. The growing demand for biopharmaceutical goods is driving notable trends in the host cell protein testing market in South Korea. The nation's robust biotechnology sector, which is supported by government policies that encourage innovation and research, is the main driver of this expansion.

Market Overview

The market for goods and services pertaining to locating, measuring, and describing host cell proteins (HCPs) in biopharmaceutical products is included in the host cell protein (HCP) testing market. In order to guarantee product quality, safety, and regulatory compliance, this testing is essential. This testing guarantees adherence and averts possible product recalls or penalties. HCPs have the potential to disrupt downstream procedures, affecting the yield and purity of the final product. Manufacturers can reduce their influence and optimize purifying strategies by evaluating HCP levels. By making it possible to produce safe, high-quality biologics, the market for HCP testing aids in the expansion and advancement of the biopharmaceutical sector. The usage of biologics and biosimilars to treat chronic illnesses is growing, which has increased the demand for HCP testing to guarantee the safety and purity of the products. Advances in testing techniques, like ELISA-based tests, enable more accurate and effective HCP identification and measurement. The need for HCP testing is rising as a result of governments enforcing more stringent laws to guarantee the efficacy and safety of biopharmaceuticals. Rapid developments in analytical technologies, like mass spectrometry-based tests and ELISA, are enhancing sensitivity and specificity in the market.

Report Coverage

This research report categorizes the market for South Korea host cell protein testing market based on various segments and regions forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea host cell protein testing market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each South Korea host cell protein testing market sub-segment.

Driving Factors

A wide range of illnesses, and biologics such as therapeutic proteins, vaccines, and monoclonal antibodies are seeing tremendous expansion. The market is growing as a result of the emergence of biosimilars, which are comparable to biological medications. To guarantee the safety and effectiveness of the product, this rising demand calls for stricter quality control procedures, such as HCP testing. Advances in analytical methods like mass spectrometry and ELISA have improved the sensitivity and precision of HCP detection. These developments make it possible to characterize HCPs in greater detail, which improves our knowledge of their possible effects on medication performance.

Restraining Factors

In a competitive industry where time to market is critical, protracted testing processes might hinder the development and introduction of innovative biopharmaceutical medicines. Some businesses may not be able to carry out comprehensive testing because the demand for specialist knowledge in HCP testing and characterization may outstrip the supply. Some HCP testing techniques might be complex and call for specific training and expertise. For smaller businesses or those with less seasoned employees, this could be a hurdle.

Market Segmentation

The South Korea host cell protein testing market share is classified into type and end user.

• The PCR-based assays segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea host cell protein testing market is segmented by type into PCR-based assays, ELISA-based assays, mass spectrometry-based assays, and others. Among these, the PCR-based assays segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. A popular option in many labs, PCR-Based Assays are known for their accuracy and capacity to identify trace amounts of host cell proteins. By using the specificity of DNA amplification, these assays give researchers the accurate results they need to comply with regulations during the drug-production process.

• The contract research organizations segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korean host cell protein testing market is segmented by end user into contract research organizations, biopharmaceutical companies, and others. Among these, the contract research organizations segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. The streamline testing procedures for a range of clients, Contract Research Organizations (CROs) are becoming more and more noticeable in this environment, demonstrating the expanding trend of outsourcing laboratory work.  

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea host cell protein testing market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Samsung Biologics
• SK Bioscience
• GC Biopharma (Green Cross)
• Celltrion
• Daewoong Pharmaceutical
• Genofocus
• Genomine
• Jeio Tech
• Curiosis
• Seegene
• Helixmith
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea host cell protein testing market based on the below-mentioned segments:

South Korea Host Cell Protein Testing Market, By Type

• PCR-Based Assays
• ELISA-Based Assays
• Mass Spectrometry-Based Assays
• Others

South Korea Host Cell Protein Testing Market, By End User

• Contract Research Organizations
• Biopharmaceutical Companies
• Others